Effects of adenosine receptor antagonists on amitriptyline-induced QRS prolongation in isolated rat hearts

• Published in: Clinical toxicology (Philadelphia, Pa.) Vol. 46; no. 7; pp. 677 - 685
• Main Authors: AKGUN, Aylin, KALKAN, Sule, HOCAOGLU, Nil, GIDENER, Sedef, TUNCOK, Yesim
• Format: Journal Article
• Language: English
• Published: Philadelphia, PA Taylor & Francis 01.08.2008
• Subjects: Amitriptyline - toxicity; Animals; Biological and medical sciences; Caffeine - analogs & derivatives; Caffeine - pharmacology; Dose-Response Relationship, Drug; Drug toxicity and drugs side effects treatment; Heart - drug effects; Heart Diseases - chemically induced; Heart Diseases - drug therapy; In Vitro Techniques; Male; Medical sciences; Pharmacology. Drug treatments; Purinergic P1 Receptor Antagonists; Random Allocation; Rats; Rats, Wistar; Toxicity: cardiovascular system; Xanthines - pharmacology; Heart; Purine nucleoside; Rat; Psychotropic; Toxicity; QRS interval; Electrophysiology; Reuptake inhibitor; Isolated organ; Antidepressant agent; Antagonist; Human; Adenosine receptor antagonists; Adenosine; Amitriptyline; Serotonin; Rodentia; Catecholamine; Tricyclic compound; Vertebrata; Mammalia; Animal; Neurotransmitter; Isolated rat heart; Norepinephrine; Circulatory system; Adenosine receptor
• ISSN: 1556-3650; 1556-9519
• DOI: 10.1080/15563650701338237

We investigated the effects of adenosine receptor antagonists on amitriptyline-induced cardiotoxicity in isolated rat hearts. The amitriptyline concentrations that prolonged the QRS duration more than 150% (10(-4) M) and 50-75% (5.5 x 10(-5) M) were accepted as the control groups for two experimental protocols, respectively. In the first protocol, amitriptyline (10(-4) M) was infused following pretreatment with a selective adenosine A(1) receptor antagonist, DPCPX (8-cyclopentyl-1,3-Dipropylxanthine,10(-4) to 10(-6) M) or a selective adenosine A(2a) receptor antagonist, CSC (8-3-chlorostyryl-caffeine,10(-4) to 10(-6) M). In the second protocol, amitriptyline (5.5 x 10(-5) M) was infused following pretreatment with DPCPX (10(-4) M) or CSC (10(-5) M). Left ventricular developed pressure (LVDP), dp/dt(max), QRS duration and heart rate (HR) were measured. In the first protocol, 10(-4) M DPCPX pretreatment shortened QRS duration at 50 minutes when compared to the control group (p < 0.05). In the second protocol, pretreatment with 10(-4) M DPCPX shortened the QRS duration at 40, 50, and 60 minutes after amitriptyline infusion when compared to the control group (p < 0.05, p < 0.01 and p < 0.05, respectively). Pretreatment with 10(-5) M CSC prolonged QRS duration at 20, 30, and 60 minutes (p < 0.05). Amitriptyline infusion following pretreatment with DPCPX or CSC did not change LVDP, dp/dt(max), or HR when compared to control in both protocols (p > 0.05). While 10(-4) M DPCPX shortened QRS prolongation, 10(-5) M CSC prolonged QRS duration in the isolated rat hearts with prolonged QRS duration induced by 5.5 x 10(-5)M amitriptyline. An adenosine A(1) receptor antagonist, DPCPX, might shorten amitriptyline-induced QRS prolongation by activating beta adrenergic receptors.